News & Events

July 23, 2019 – Banner Life Sciences Announces First Subject Enrolled in Randomized, Double-Blind Head-to-Head Study of Bafiertam and Tecfidera for Comparative Assessment of GI Tolerability

View full release as a pdf here:

Banner Announces Head-to-Head Study of BAFIERTAM .pdf (99.3 KB)


January 02, 2019 – Banner Receives FDA Tentative Approval for BAFIERTAM for the Treatment of Relapsing Forms of Multiple Sclerosis

View full release as a pdf here:

BAFIERTAM FDA Tentative Approval 01 02 2019.pdf (69.9 KB)